eleven patients with hyperlipoproteinemia ( hlp ) type ii a , were treated for 3 months with a new compound , a phenoxy-isobuturic acid derivative , procetofen , at a dosage of 100 mg t.i.d .
C0020476
hyperlipoproteinemia
C0033228
procetofen